Delvys Rodríguez‐Abreu

Researcher Next ID · RN-003001

Researcher · Medicine

Las Palmas de Gran Canaria, Spain

Not currently recruitingFunding unknown

Research interests

Medicine

Cancer Immunotherapy and Biomarkers

Lung Cancer Treatments and Mutations

Lung Cancer Diagnosis and Treatment

Lung Cancer Research Studies

Lymphoma Diagnosis and Treatment

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1801005
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1716948
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1613493
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1606774
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(11)70393-x

No projects listed.